Your browser doesn't support javascript.
loading
Recurrent orbital inflammation associated with VEXAS syndrome.
Beecher, Mark B; Tong, Jessica Y; Halliday, Luke A; Hissaria, Pravin; Selva, Dinesh.
Afiliación
  • Beecher MB; Discipline of Ophthalmology and Visual Sciences, University of Adelaide, Adelaide, Australia.
  • Tong JY; Discipline of Ophthalmology and Visual Sciences, University of Adelaide, Adelaide, Australia.
  • Halliday LA; South Australian Institute of Ophthalmology, Royal Adelaide Hospital, Adelaide, Australia.
  • Hissaria P; Discipline of Ophthalmology and Visual Sciences, University of Adelaide, Adelaide, Australia.
  • Selva D; South Australian Institute of Ophthalmology, Royal Adelaide Hospital, Adelaide, Australia.
Orbit ; : 1-4, 2022 Sep 27.
Article en En | MEDLINE | ID: mdl-36168114
ABSTRACT
VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome is a newly recognised adult-onset multisystem autoinflammatory disease caused by a somatic mutation in the UBA1 gene in myeloid or erythroid precursor cells. This report describes an atypical presentation of recurrent dacryoadenitis associated with VEXAS syndrome and provides a review of the literature. A 68-year-old male presented with three episodes of unilateral alternating dacryoadenitis followed by bilateral involvement over a 4-year period. Each episode of orbital inflammation was characterised by upper lid swelling, oedema and enlarged lacrimal glands. In addition, he experienced intermittent flares of angioedema-like lesions involving the face and extremities, recurrent jaw aches, rash, progressive pulmonary fibrosis, and myelodysplastic syndrome. His inflammatory symptoms lessened with prednisolone but were refractory to methotrexate. Mycophenolate was subsequently trialled with a reasonable clinical response. Genetic testing established the diagnosis of VEXAS syndrome and tofacitinib, a JAK inhibitor, was commenced with resolution of inflammatory symptoms.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Orbit Año: 2022 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Orbit Año: 2022 Tipo del documento: Article País de afiliación: Australia